OVEREXPRESSION OF DOMINANT NEGATIVE TRANSFORMING GROWTH FACTOR (TGF)-β TYPE II RECEPTOR (DnTGFβRII) ATTENUATES PRESSURE OVERLOAD-INDUCED CARDIAC REMODELING AND DYSFUNCTION

被引:0
|
作者
Lucas, J. A. [1 ]
Miller, A. P. [1 ]
Zhang, Y. [1 ]
Li, P. [1 ]
Oparil, S. [1 ]
Chen, Y. [1 ]
机构
[1] Univ Alabama, Birmingham, AL USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:301 / 301
页数:1
相关论文
共 50 条
  • [31] A dominant negative mutation of transforming growth factor-β receptor type II gene in microsatellite stable oesophageal carcinoma
    Tanaka, S
    Mori, M
    Mafune, K
    Ohno, S
    Sugimachi, K
    BRITISH JOURNAL OF CANCER, 2000, 82 (09) : 1557 - 1560
  • [32] A dominant negative mutation of transforming growth factor- β receptor type II gene in microsatellite stable oesophageal carcinoma
    Shinji Tanaka
    Masaki Mori
    Ken-ichi Mafune
    Shinji Ohno
    Keizo Sugimachi
    British Journal of Cancer, 2000, 82 (9) : 1557 - 1560
  • [33] Requirement of transforming growth factor-beta (TGF-beta) type II receptor for TGF-beta-induced proliferation and growth
    Zhao, Y
    Young, SL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (05) : 2369 - 2372
  • [34] Overexpression of transforming growth factor (TGF) β1 type II receptor restores TGF-β1 sensitivity and signaling in human prostate cancer cells
    Guo, YP
    Kyprianou, N
    CELL GROWTH & DIFFERENTIATION, 1998, 9 (02): : 185 - 193
  • [35] A dominant negative mutant transforming growth factor-beta type II receptor blocks antiproliferative effects of TGF-beta 1 in mesangial cells.
    Choi, ME
    Madabhushi, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2034 - A2034
  • [36] DIFFERENTIAL REGULATION OF TRANSFORMING GROWTH FACTOR-BETA-3 IN CARDIAC NON-MYOCYTES WITH PRESSURE VERSUS VOLUME OVERLOAD-INDUCED VENTRICULAR HYPERTROPHY
    CALDERONE, A
    TAKAHASHI, N
    COLUCCI, WS
    CIRCULATION, 1994, 90 (04) : 194 - 194
  • [37] Soluble transforming growth factor β type II receptor attenuates TGF-β1 activity in human colorectal cancer LoVo cells
    Zhou, Rui
    Xiong, Bin
    Song, Haibin
    Liu, Shiquan
    Wang, Xinbo
    ONCOLOGY REPORTS, 2008, 20 (06) : 1449 - 1456
  • [38] Soluble transforming growth factor-β type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth
    Smith, JD
    Bryant, SR
    Couper, LL
    Vary, CPH
    Gotwals, PJ
    Koteliansky, VE
    Lindner, V
    CIRCULATION RESEARCH, 1999, 84 (10) : 1212 - 1222
  • [39] Dominant-negative inhibition of transforming growth factor-beta type II receptor reveals alternative signaling pathways.
    Choi, ME
    Madabhushi, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2291 - A2291
  • [40] Induction of colonic neoplasia in transgenic mice bearing a dominant negative transforming growth factor beta type II receptor gene.
    Peeler, MO
    Serra, R
    Hooton, EB
    Lamps, L
    Shyr, Y
    Moses, HL
    Beauchamp, RD
    GASTROENTEROLOGY, 1997, 112 (04) : A637 - A637